Valeant becomes Bausch Health Companies

Valeant becomes Bausch Health Companies

16 July 2018 - Deborah Wilkes

Canada's Valeant Pharmaceuticals International has now changed its name to Bausch Health Companies, reflecting the importance of the Bausch + Lomb eyecare business acquired in 2013.

Chairman and chief executive officer Joseph Papa said Bausch had "long been a highly-respected name in the healthcare space, synonymous for 165 years with innovation and unwavering dedication to improving people's lives".

"It is a legacy that defines us today and sets the stage for our future as we continue to transform the company," added Papa.

Announcing the change in May 2018, Papa said the new name "more accurately represents the full scope of the company today".

The company, noted Papa, was a leader in the development and manufacture of a wide range of pharmaceutical, medical device and OTC products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology (click here to read the News story).

Bausch Health said businesses and subsidiaries with separate established brands would continue to operate under the corporate umbrella using their existing names.

Take out an Annual Subscription to the OTCToolbox website, giving you UNLIMITED ACCESS to all of our publications
* OTCToolbox Innovations magazine NEW IDEAS BETTER WAYS
* OTCToolbox Deals Database
* Premium News Stories
* News Extras
* OTC Deal Trends Briefing
* OTC Company Strategies Report
Helping you and your company make well-informed decisions

Back to Industry News

Share this page: